Novian Health

Novian Health

Novian Health is a Chicago-based medical device company with a subsidiary in Evry, France. It has developed Novilase, an image-guided laser therapy to focally destroy malignant and benign breast tumors. Intended as a minimally-invasive alternative to surgery, Novilase uses parametrically controlled heating for the ablation of tumors. Image-guided treatment of breast tumors is the first application of the technology, with the potential for Novilase to focally destroy solid tumors elsewhere in the body.

Product
Novilase® Breast Therapy, is a FDA cleared laser treatment of fibroadenomas or benign breast tumors. It has been evaluated in clinical trials for focal destruction of malignant breast tumors. In Europe, Novilase has received a CE Mark for focal destruction of malignant and benign breast tumors.  In the USA, a pivotal study evaluating Novilase for focal destruction of malignant breast tumors will begin enrolling in 2021.